Nasdaq International Designation Virtual Investor Conference Presentation

20 September 2018

CLINUVEL PHARMACEUTICALS LTD (ASX: CUV; XETRA-DAX: UR9; NASDAQ INTERNATIONAL DESIGNATION: CLVLY) presented to the Nasdaq Virtual Investor Conference on Wednesday 19 September. A copy of the presentation is appended.

Download PDF to read more

We use cookies to give you the best experience.